SelectPSMA

Personalized Treatment Predictions

AI-powered predictions of patient outcomes following treatment with PSMA-targeted radiopharmaceuticals, helping to avoid ineffective treatments and side effects.

Patient Selection

Identifies patients unlikely to benefit from treatment with 177Lu-PSMA-617.

Precision Medicine

Improves patient outcome while minimizing treatment-related side effects.

Evidence-Based Decisions

Assists phyisicians in clinical decision-making process with robust data.
SelectPSMA Report from Nucs AI indicating a positive Lu-PSMA biomarker result for predicting patient response to PSMA-targeted therapy, with clinical interpretation insights.

Personalized Treatment Predictions for Prostate Cancer

SelectPSMA utilizes cutting-edge AI technology to predict patient outcomes following treatment with PSMA-targeted radiopharmaceuticals.

Clinical Value

Enables improved patient selecton for 177Lu-PSMA-617 therapy and avoid futile treatments to improve patient outcome.

Benefits

Patients unlikely to benefit from Pluvicto therapy are directed towards more efficacious treatments for prostate cancer.

A smiling male doctor in a white coat holding a tablet, consulting with a patient about prostate cancer treatment options. The doctor and patient are sitting at a table in a bright clinical setting.

Applications of SelectPSMA

Explore how SelectPSMA enhances prostate cancer treatment across various settings.

Patient Selection

Identifies patients who are unlikely to benefit from treatment with 177Lu-PSMA-617.

Minimize Toxicity

Avoid futile treatments and unnecessary treatment-related side effects.

Medical Oncology

Assists medical oncologists to determine most efficacious treatment option for each individual patient.

Decision Support

Provides robust and reproducible data to support clinical decisions and improve healthcare resource allocation.

Patient Counseling

Aids in communicating to patients the likelihood of therapeutic response, helping them make informed decisions.

Contact us today

Take the next step to discover how Nucs AI can transform your clinical management of prostate cancer care.